European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa CC Zouboulis, N Desai, L Emtestam, RE Hunger, D Ioannides, I Juhász, ... Journal of the European Academy of Dermatology and Venereology 29 (4), 619-644, 2015 | 1137 | 2015 |
The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria International Team for the Revision of the International Criteria for Behçet ... Journal of the european Academy of Dermatology and Venereology 28 (3), 338-347, 2014 | 971 | 2014 |
Skin anti-aging strategies R Ganceviciene, AI Liakou, A Theodoridis, E Makrantonaki, CC Zouboulis Dermato-endocrinology 4 (3), 308-319, 2012 | 915 | 2012 |
New developments in our understanding of acne pathogenesis and treatment I Kurokawa, FW Danby, Q Ju, X Wang, LF Xiang, L Xia, WC Chen, I Nagy, ... Experimental dermatology 18 (10), 821-832, 2009 | 780 | 2009 |
Acne and sebaceous gland function CC Zouboulis Clinics in dermatology 22 (5), 360-366, 2004 | 770 | 2004 |
European evidence-based (S3) guidelines for the treatment of acne. A Nast, B Dreno, V Bettoli, K Degitz, R Erdmann, AY Finlay, ... Journal of the European Academy of Dermatology & Venereology 26, 2012 | 687 | 2012 |
Two phase 3 trials of adalimumab for hidradenitis suppurativa AB Kimball, MM Okun, DA Williams, AB Gottlieb, KA Papp, CC Zouboulis, ... New England Journal of Medicine 375 (5), 422-434, 2016 | 673 | 2016 |
Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study SZ Ghodsi, H Orawa, CC Zouboulis Journal of investigative Dermatology 129 (9), 2136-2141, 2009 | 636 | 2009 |
What is the pathogenesis of acne? CC Zouboulis, A Eady, M Philpott, LA Goldsmith, C Orfanos, WJ Cunliffe, ... Exp Dermatol 14, 143-152, 2005 | 547 | 2005 |
Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial AB Kimball, F Kerdel, D Adams, U Mrowietz, JM Gelfand, R Gniadecki, ... Annals of internal medicine 157 (12), 846-855, 2012 | 515 | 2012 |
Acne vulgaris S Moradi-Tuchayi, E Makrantonaki, R Ganceviciene, C Dessinioti, ... Nature Reviews Disease Primers 1, 15029, 2015 | 495* | 2015 |
Epidemiological features of Adamantiades-Behcet’s disease in Germany and in Europe CC Zouboulis, I Koetter, D Djawari, W Kirch, PK Kohl, FR Ochsendorf, ... Yonsei Med J 38, 411-422, 1997 | 476 | 1997 |
Current use and future potential role of retinoids in dermatology CE Orfanos, CC Zouboulis, B Almond-Roesler, CC Geilen Drugs 53, 358-388, 1997 | 470 | 1997 |
Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris T Nakatsuji, MC Kao, JY Fang, CC Zouboulis, L Zhang, RL Gallo, ... Journal of investigative dermatology 129 (10), 2480-2488, 2009 | 469 | 2009 |
What causes hidradenitis suppurativa? H Kurzen, I Kurokawa, GBE Jemec, L Emtestam, K Sellheyer, ... Experimental Dermatology 17 (5), 455-472, 2008 | 455* | 2008 |
Sexual hormones in human skin CC Zouboulis, WC Chen, MJ Thornton, K Qin, R Rosenfield Hormone and metabolic research 39 (02), 85-95, 2007 | 451 | 2007 |
Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes I Nagy, A Pivarcsi, K Kis, A Koreck, L Bodai, A McDowell, H Seltmann, ... Microbes and infection 8 (8), 2195-2205, 2006 | 451 | 2006 |
Epidemiology of Adamantiades-Behçet's disease CC Zouboulis Annales de Medecine Interne 150, 488-498, 1999 | 441 | 1999 |
Anti-TNF therapy in the management of Behçet's disease—review and basis for recommendations PP Sfikakis, N Markomichelakis, E Alpsoy, S Assaad-Khalil, B Bodaghi, ... Rheumatology 46 (5), 736-741, 2007 | 431 | 2007 |
Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95) CC Zouboulis, H Seltmann, CE Orfanos, H Neitzel Journal of Investigative Dermatology 113 (6), 1011-1020, 1999 | 404 | 1999 |